| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/17/1997 | WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA |
| 07/17/1997 | WO1997025071A2 Immunoconjugate for the treatment of aids |
| 07/17/1997 | WO1997025069A1 Antibodies with reduced net positive charge |
| 07/17/1997 | WO1997025068A2 Mesothelin antigen and methods and kits for targeting it |
| 07/17/1997 | WO1997025063A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | WO1997025061A1 De-myristolated lipopolysaccharide of gram-negative bacteria |
| 07/17/1997 | WO1997012969A3 Fmr1-related protein |
| 07/17/1997 | WO1997012042A3 Glycoprotein b of the rfhv/kshv subfamily of herpes viruses |
| 07/17/1997 | WO1997009429A3 Compounds and methods for diagnosis of tuberculosis |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | DE4499552C1 New incomplete and complete adjuvants for antigens |
| 07/17/1997 | DE3590054C1 Compositions for herpes virus infections treatment |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242866A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | CA2242778A1 Process for isolating igg and iga |
| 07/17/1997 | CA2242514A1 Immunoconjugate for the treatment of aids |
| 07/17/1997 | CA2242430A1 Calcium binding proteolipid compositions and methods |
| 07/17/1997 | CA2242340A1 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/16/1997 | EP0784059A1 Antigenic polypeptide of chlamydia pneumoniae |
| 07/16/1997 | EP0783894A1 Antibodies modified at two separate sites |
| 07/16/1997 | EP0783893A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/16/1997 | EP0783892A1 Method to increase and modify immune responses |
| 07/16/1997 | EP0783586A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 07/16/1997 | EP0783580A2 Dna sequence and protein of the non-structural reading frame i of the human parvovirus b19 |
| 07/16/1997 | EP0783579A2 THE tagA GENE AND METHODS FOR DETECTING PREDISPOSITION TO PEPTIC ULCERATION AND GASTRIC CARCINOMA |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783571A1 Flt-4 (fms-like tyrosine-kinase), flt-15, variants thereof uses as growth factor inhibitors |
| 07/16/1997 | EP0783526A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 07/16/1997 | EP0783525A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 07/16/1997 | EP0783524A1 Peptides and pharmaceutical compositions comprising them |
| 07/16/1997 | EP0783522A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 07/16/1997 | EP0783520A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783322A1 Peptide compositions capable of down regulating an antigen specific immune response |
| 07/16/1997 | EP0783321A1 Vr-2332 viral nucleotide sequence and methods of use |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0783299A1 Compounds and compositions for delivering active agents |
| 07/16/1997 | EP0642523B1 Ganglioside analogs |
| 07/16/1997 | EP0583281B1 Antivenom immunesera |
| 07/16/1997 | EP0459978B1 Class i mhc modulation of surface receptor activity |
| 07/16/1997 | CN1154718A Identification of a human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression |
| 07/16/1997 | CN1154655A Method of purifying necrotoxin produced by bordetella and Toxoid |
| 07/15/1997 | US5648472 Process for preparing virus-inactivated immunoglobulin solutions |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 07/15/1997 | US5648332 Method of treating diabetes mellitus using variable α domain of T-cell receptor |
| 07/15/1997 | US5648273 Hepatic growth factor receptor is the MET proto-oncogene |
| 07/15/1997 | US5648260 Immunoglobulins |
| 07/15/1997 | US5648259 Polypeptides having NMDA receptor activity, nucleic acids encoding those polypeptides and applications |
| 07/15/1997 | US5648240 MHC II analog from Staphylococcus aureus |
| 07/15/1997 | US5648239 Human camp-dependent protein kinase inhibitor homolog |
| 07/15/1997 | US5648081 Actinobacillus pleuropneumoniae subunit vaccine |
| 07/15/1997 | US5648080 Antigenic preparations and isolation of such preparations |
| 07/15/1997 | US5648079 Herpes simplex virus glycoprotein B vaccine |
| 07/15/1997 | US5648076 Administering antigrowth factor antibodies following surgery |
| 07/15/1997 | US5648074 Polyanionic compound, chlorine dioxide |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |
| 07/15/1997 | US5648059 Methods for reducing non-target retention of immunoconjugates and metabolites thereof |
| 07/10/1997 | WO1997024450A1 Method for immunizing and treating human cells in animal organs maintained in vitro |
| 07/10/1997 | WO1997024447A1 Immunostimulation mediated by gene-modified dendritic cells |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024440A1 Ob protein derivatives having prolonged half-life |
| 07/10/1997 | WO1997024438A1 Immunostimulatory composition and method |
| 07/10/1997 | WO1997024143A1 Cytotoxic agents |
| 07/10/1997 | WO1997024139A1 Peanut allergens and methods |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024132A1 Allogeneic paracrine cytokine tumor vaccines |
| 07/10/1997 | WO1997011682A3 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/10/1997 | WO1997007769A3 Chemical compounds |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/10/1997 | CA2238307A1 Ob protein derivatives having prolonged half-life |
| 07/09/1997 | EP0783104A1 Method for assaying soluble amyloid precursor protein |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0783037A1 Polypeptides with a dopaminergic receptor (D2-R and D3-R) activity and use of these polypeptides to screen substances having a selective activity on these polypeptides |
| 07/09/1997 | EP0782860A1 Polymerized vaccines |
| 07/09/1997 | EP0782859A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| 07/09/1997 | EP0782619A1 Novel pka-binding proteins and uses thereof |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782579A1 Dna photocleavage using texaphyrins |
| 07/09/1997 | EP0782453A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 07/09/1997 | EP0663836B1 Treatment of autoimmune and inflammatory disorders |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154069A Polyepitope vaccines |
| 07/09/1997 | CN1154068A Pharmaceutical compositions comprising a chimaeric TNF binding protein |
| 07/08/1997 | US5646259 DNA encoding haemophilus adhesion proteins |
| 07/08/1997 | US5646247 Merozoite antigens localized at the apical end of the parasite |
| 07/08/1997 | US5646123 Time dependent administration of oligosaccharide glycosides related to blood group determinants having a type I or type II core structure in reducing inflammation in a sensitized mammal arising form exposure to an antigen |
| 07/08/1997 | US5646115 Diagnosing allergic dermatitis; desensitizing animals to flea bites |
| 07/08/1997 | US5646109 Convertible microemulsion formulations |
| 07/08/1997 | US5646040 Mammalian tub gene |
| 07/08/1997 | US5646033 African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/08/1997 | US5646011 Overcoming resistance of tumor cells to chemotheraputic agents, gene expression |
| 07/08/1997 | US5646008 Vertebrate apoptosis gene: compositions and methods |
| 07/08/1997 | US5645998 Detection of immunocomplex formed by glutamic acid decarboxylase protein with autoantibodies |